RU2012122468A - COMPOSITION FOR TREATMENT OF SKIN INJURIES - Google Patents

COMPOSITION FOR TREATMENT OF SKIN INJURIES Download PDF

Info

Publication number
RU2012122468A
RU2012122468A RU2012122468/15A RU2012122468A RU2012122468A RU 2012122468 A RU2012122468 A RU 2012122468A RU 2012122468/15 A RU2012122468/15 A RU 2012122468/15A RU 2012122468 A RU2012122468 A RU 2012122468A RU 2012122468 A RU2012122468 A RU 2012122468A
Authority
RU
Russia
Prior art keywords
composition
ointment base
lanolin
treatment
phenol
Prior art date
Application number
RU2012122468/15A
Other languages
Russian (ru)
Other versions
RU2539378C2 (en
Inventor
Виталий Владиславович Радченко
Маргарита Владимировна Александрова
Татьяна Маратовна Шуваева
Елена Вячеславовна Ильницкая
Владимир Иванович Новоселов
Марс Галиевич Шарапов
Original Assignee
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) filed Critical Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority to RU2012122468/15A priority Critical patent/RU2539378C2/en
Publication of RU2012122468A publication Critical patent/RU2012122468A/en
Application granted granted Critical
Publication of RU2539378C2 publication Critical patent/RU2539378C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Состав для лечения повреждений кожи, включающий лекарственное средство и мазевую основу, отличающийся тем, что в качестве лекарственного средства он содержит суспензию микробных клеток непатогенного бесплазмидного штамма Еcoliпроизводящих рекомбинантный пероксиредоксин 6 человека идентичный по аминокислотной последовательности природному белку, а мазевая основа содержит вазелин, ланолин, физиологический раствор и фенол в качестве консерванта при следующем соотношении компонентов, г:A composition for treating skin lesions, including a drug and an ointment base, characterized in that it contains a suspension of microbial cells of a non-pathogenic non-plasmid strain Еcoli producing recombinant human peroxyredoxin 6 identical in amino acid sequence to a natural protein, and the ointment base contains vaseline, lanolin, physiological solution and phenol as a preservative in the following ratio of components, g:

Claims (1)

Состав для лечения повреждений кожи, включающий лекарственное средство и мазевую основу, отличающийся тем, что в качестве лекарственного средства он содержит суспензию микробных клеток непатогенного бесплазмидного штамма Е. coli, производящих рекомбинантный пероксиредоксин 6 человека идентичный по аминокислотной последовательности природному белку, а мазевая основа содержит вазелин, ланолин, физиологический раствор и фенол в качестве консерванта при следующем соотношении компонентов, г:Composition for the treatment of skin lesions comprising a drug and an ointment base, characterized in that as a drug it comprises a suspension of microbial cells besplazmidnogo non-pathogenic strain of E. coli, producing a recombinant human peroxiredoxin 6 identical in amino acid sequence to the natural protein, and ointment base comprises petrolatum, lanolin, saline and phenol as a preservative in the following ratio, g: суспензия микробных клеток штамма-продуцентаmicrobial suspension of producer strain   в физиологическом растворе, содержащаяin saline containing   не менее 330 млн. клетокno less than 330 million cells 150-200 мг150-200 mg фенолphenol 5 мг5 mg смесь 5 частей вазелина аптечного и 2 частей ланолинаa mixture of 5 parts of Vaseline pharmacy and 2 parts of lanolin до 1 гup to 1 g
RU2012122468/15A 2012-05-31 2012-05-31 Formulation for treating skin damages RU2539378C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Publications (2)

Publication Number Publication Date
RU2012122468A true RU2012122468A (en) 2013-12-10
RU2539378C2 RU2539378C2 (en) 2015-01-20

Family

ID=49682661

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Country Status (1)

Country Link
RU (1) RU2539378C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000005467A1 (en) * 2020-03-13 2021-09-13 Univ Degli Studi Di Roma “Tor Vergata” Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycemic agent.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2280448C2 (en) * 2002-11-10 2006-07-27 Институт биофизики клетки РАН Composition with antioxidant property and method for treatment of disease in mammals

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000005467A1 (en) * 2020-03-13 2021-09-13 Univ Degli Studi Di Roma “Tor Vergata” Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycemic agent.
WO2021181436A1 (en) * 2020-03-13 2021-09-16 Università Degli Studi di Roma "Tor Vergata" Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycaemic agent

Also Published As

Publication number Publication date
RU2539378C2 (en) 2015-01-20

Similar Documents

Publication Publication Date Title
BR112017024777A2 (en) use of a pharmaceutical composition and a non-absorbable antibiotic for treating autistic spectrum disorder cross reference to related applications?
NZ702637A (en) Treatment of amd using aav sflt-1
EA201201661A1 (en) NEW AMINOPYRAZOLOHINAZOLINES
BR112013026032A2 (en) nutritional compositions including branched chain fatty acids for wound healing
CY1118073T1 (en) COMPOSITIONS AND METHODS FOR INCREASING THE TELECOMMUNICATION ACT
EA200702523A1 (en) APPLICATION OF ERYTHROPOIETHIN IN LOW DOSAGE FOR STIMULATION OF ENDOTHELIAL CELLS PRECONDENTS, AND ALSO FOR REGENERATION OF ORGANS AND SLOWING PROGRESSION OF DAMAGES OF FINAL ORGANS
EP3818991A3 (en) Compositions and methods for treating diseases
EA200800397A1 (en) TIZANIDINE COMPOSITIONS AND TREATMENT METHODS USING COMPOSITIONS
RU2010126868A (en) PHARMACEUTICAL COMPOSITION INTENDED FOR THE TREATMENT OF DISEASES OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF VASCULAR, TRUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS
EA201391063A1 (en) APOLIPOPROTEIN A-IV AS ANTIDIABETIC PEPTIDE
RU2012122468A (en) COMPOSITION FOR TREATMENT OF SKIN INJURIES
EA202190798A1 (en) ROTAMERIC ISOMERS OF 4-ALKYL-5-HETEROARYL-3H-1,2-DITHIOL-3-THIONES
RU2008113403A (en) DRUG FOR PROCESSING ORGANIC WASTE "ECOS"
BRPI0612456A2 (en) compositions and methods for the treatment of malaria with cupredoxin and cytochrome
EA201591095A1 (en) PROTEIN SLURP-1 FOR USE IN THE TREATMENT OF EYE DISEASES
RU2014144507A (en) METHOD AND MEANS FOR TREATING AN ACID DISEASE
RU2012145513A (en) METHOD FOR PRODUCING INTEGRATED PRODUCT WITH IMMUNOMETABOLIC AND ANTHELMINTIC ACTIVITY
BR112018073201A2 (en) immunogenic composition for cancer treatment and methods of cancer preparation
RU2010146519A (en) COMPOSITION OF BIOLOGICALLY ACTIVE PREPARATIONS TO INCREASE THE SURVIVAL OF STURGEON FISH IN ARTIFICIAL REPRODUCTION
RU2008137463A (en) DRUG FOR TREATMENT AND PREVENTION OF DISORDERS OF SELENIUM EXCHANGE FOR AGRICULTURAL ANIMALS
RU2008100977A (en) "DIARON" PREPARATION FOR TREATMENT OF ACUTE GASTROINTESTINAL DISEASES OF NEWBORN CALVES
RU2010126820A (en) PREBIOTIC, STIMULATING VAGINAL LACTOFLORA GROWTH
MX2022014888A (en) Mono- and bis-nitrosylated propanediols for therapeutic use.
RU2007138452A (en) METHOD FOR TREATING FUR ANIMALS WITH ODODECTOSIS
RU2012100471A (en) MEDICAL AND COSMETIC PRODUCT

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20170601